Search for: "Freedom Pharmaceuticals, Inc" Results 121 - 140 of 152
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jun 2010, 5:26 pm by INFORRM
” discussed the comments of Robin Bierstedt on her retirement as Time Inc’s legal counsel. [read post]
13 Apr 2010, 10:26 am
See generally Ariad Pharmaceuticals, Inc. v. [read post]
2 Feb 2010, 11:25 am by Editor
Those who took the time and made the effort to nominate their personal recommendations for Blawg Review of the Year 2009 know how daunting a task it is to single out a half dozen outstanding presentations of Blawg Review in 2009. [read post]
2 Feb 2010, 11:25 am by Editor
Those who took the time and made the effort to nominate their personal recommendations for Blawg Review of the Year 2009 know how daunting a task it is to single out a half dozen outstanding presentations of Blawg Review in 2009. [read post]
16 Nov 2009, 4:51 am
(Class 99) United States US General Wisconsin judge vacates $ 1.26 billion judgment in default against PepsiCo (IPKat) (IP Factor) California Court of Appeal: Von Dutch tradename settlement gives rise to legal malpractice action and questionable mediation confidentiality decision: Michael Cassel v Superior Court of Los Angeles County (The IP ADR Blog) US Patent Reform Putting the USPTO to work for independent inventors (Director's Forum) (Inventive Step) (IP Asset Maximizer Blog) (Patently-O)… [read post]
16 Nov 2009, 4:51 am
(Class 99)   United States US General Wisconsin judge vacates $ 1.26 billion judgment in default against PepsiCo (IPKat) (IP Factor) California Court of Appeal: Von Dutch tradename settlement gives rise to legal malpractice action and questionable mediation confidentiality decision: Michael Cassel v Superior Court of Los Angeles County (The IP ADR Blog)   US Patent Reform Putting the USPTO to work for independent inventors (Director's Forum) (Inventive Step) (IP Asset Maximizer Blog)… [read post]
16 Nov 2009, 4:51 am
(Class 99) United States US General Wisconsin judge vacates $ 1.26 billion judgment in default against PepsiCo (IPKat) (IP Factor) California Court of Appeal: Von Dutch tradename settlement gives rise to legal malpractice action and questionable mediation confidentiality decision: Michael Cassel v Superior Court of Los Angeles County (The IP ADR Blog) US Patent Reform Putting the USPTO to work for independent inventors (Director's Forum) (Inventive Step) (IP Asset Maximizer Blog) (Patently-O)… [read post]
6 Oct 2009, 12:13 pm
Allergan Inc., the company that produces the Botox wrinkle treatment, has filed a lawsuit against the Food and Drug Administration (FDA) claiming that the FDA prohibitions on off-label marketing violate the company's right to freedom of speech. [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360)   Global - Copyright Expanding the public domain: part zero (Creative Commons)     Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian Trade… [read post]
23 Dec 2008, 7:00 pm
It was withdrawn at Par Pharmaceuticals based on the Board of Directors' commitment to adopt the policy in 2009. [read post]
15 Oct 2008, 9:03 pm
Solvay Pharmaceuticals, Inc., 2008 WL 4177927 (M.D. [read post]
19 Sep 2008, 6:00 pm
You can separately subscribe to the IP Think Tank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Electronic Frontier Foundation and Public Knowledge sue US Trade Representative over allegedly insufficient disclosure under US Freedom of Information Act concerning Anti-Counterfeiting Trade Agreement negotiations: (EFF), (Public Knowledge), (Intellectual Property Watch), (Ars Technica), (Excess Copyright), (Public Knowledge),… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
16 May 2008, 8:03 am
– Discussion of Neil Netanel’s book ‘Copyright’s parado&xrsquo;: (Techdirt), Derivative works, evergreening and copyright freedom to operate: (IP ThinkTank), Events 19 May: 4th annual ‘meet the bloggers’ session – Berlin: (IPKat), (Catch Us If You Can!!!) [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]